Ryan H. Moy

Sep 1, 2023 | thelancet.com | Samuel Cytryn |Ryan H. Moy |Darren Cowzer |Joanne F. Chou

Research in contextEvidence before this studyWe searched PubMed for published studies from database inception until April 1, 2023, using the search terms (“gastric cancer” OR “gastroesophageal cancer” OR “esophageal cancer”) AND (“regorafenib” OR “PD-1 inhibitor” OR “PD-L1 inhibitor”). The search was restricted to clinical trials with no language restrictions.